FLGT
Quality Rating
Fulgent Genetics, Inc. (FLGT) operates in the healthcare diagnostics sector, providing genetic and molecular testing services that align with Shariah principles on permissible business activities. Financial screening reveals compliance in debt and income ratios but failure in liquidity due to excessive cash holdings exceeding thresholds across standards. The company is not included in any major Shariah indices, leading to an overall non-compliant status. Purification is required at 2.6% for non-permissible income elements. Investors should monitor liquidity management for potential future compliance.
Purification Required
Moderate purification required - consider carefully
Index Inclusion
Not included in S&P Dow Jones Shariah Indices, MSCI Islamic Indices, FTSE Shariah Indices, or Dow Jones Islamic Market (DJIM).
Key Compliance Considerations
- Liquidity ratio exceeds 30-33% thresholds across AAOIFI, MSCI, and S&P standards
- High cash and interest-bearing securities relative to market cap
Debt Ratio
1.2%
Liquidity Ratio
50.0%
Interest Income Ratio
2.6%
Purification
2.60%